Amphastar Pharmaceuticals, Inc. (AMPH) — Business segments and KPIs
Revenue by business segment and geography for Amphastar Pharmaceuticals, Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Epinephrine | 70.64M | 100.0% |
| Revenue by region | ||
| UNITED STATES | 681.42M | 94.7% |
| France | 35.28M | 4.9% |
| China | 3.18M | 0.4% |